Gene · 5792
Papers2,345
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,345
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic and molecular mechanisms of spine color formation in Chinese red chestnut. | Front Plant Sci | 2024 | 38835869 | PubTator, text mining | PubMed |
| Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype. | Breast Cancer | 2024 | 38777987 | PubTator, text mining | PubMed |
| Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification. | Sci Rep | 2024 | 38760384 | PubTator, text mining | PubMed |
| Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC). | Indian J Surg Oncol | 2024 | 38741650 | PubTator, text mining | PubMed |
| Burdock miR8175 in diet improves insulin resistance induced by obesity in mice through food absorption. | iScience | 2024 | 38660399 | PubTator, text mining | PubMed |
| Subtyping of triple-negative breast cancers: its prognostication and implications in diagnosis of breast origin. | ESMO Open | 2024 | 38613910 | PubTator, text mining | PubMed |
| Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy. | Cancer Cell Int | 2024 | 38594722 | PubTator, text mining | PubMed |
| Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes. | JCO Precis Oncol | 2024 | 38484209 | PubTator, text mining | PubMed |
| Author Correction: Specification of neural circuit architecture shaped by context-dependent patterned LAR-RPTP microexons. | Nat Commun | 2024 | 38453970 | PubTator, text mining | PubMed |
| Prognostic value of lactic dehydrogenase-to-albumin ratio in critically ill patients with acute respiratory distress syndrome: a retrospective cohort study. | J Thorac Dis | 2024 | 38410562 | PubTator, text mining | PubMed |
| Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances. | Pharmaceuticals (Basel) | 2024 | 38399444 | PubTator, text mining | PubMed |
| Non-Mature miRNA-Encoded Micropeptide miPEP166c Stimulates Anthocyanin and Proanthocyanidin Synthesis in Grape Berry Cells. | Int J Mol Sci | 2024 | 38338816 | PubTator, text mining | PubMed |
| Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin-like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer. | MedComm (2020) | 2024 | 38292328 | PubTator, text mining | PubMed |
| Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer. | Cell Death Discov | 2024 | 38286854 | PubTator, text mining | PubMed |
| Experimental Studies on the Therapeutic Potential of Vaccinium Berries in Breast Cancer-A Review. | Plants (Basel) | 2024 | 38256707 | PubTator, text mining | PubMed |
| Neurodegenerative Disease: From Molecular Basis to Therapy. | Int J Mol Sci | 2024 | 38256040 | PubTator, text mining | PubMed |
| Analysis of Receptor-Type Protein Tyrosine Phosphatase Extracellular Regions with Insights from AlphaFold. | Int J Mol Sci | 2024 | 38255894 | PubTator, text mining | PubMed |
| Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review. | Med Sci (Basel) | 2024 | 38249081 | PubTator, text mining | PubMed |
| Transcriptomic analysis of glucosidase II beta subunit (GluIIß) knockout A549 cells reveals its roles in regulation of cell adhesion molecules (CAMs) and anti-tumor immunity. | BMC Genomics | 2024 | 38245670 | PubTator, text mining | PubMed |
| AIbZIP/CREB3L4 Promotes Cell Proliferation via the SKP2-p27 Axis in Luminal Androgen Receptor Subtype Triple-Negative Breast Cancer. | Mol Cancer Res | 2024 | 38236913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5792/papers?page=8